These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6381447)

  • 1. Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and binding.
    Koupal LR; Pelak BA; Cassidy PJ; Gadebusch HH
    J Antibiot (Tokyo); 1983 Jan; 36(1):54-63. PubMed ID: 6381447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins.
    Satta G; Cornaglia G; Mazzariol A; Golini G; Valisena S; Fontana R
    Antimicrob Agents Chemother; 1995 Apr; 39(4):812-8. PubMed ID: 7785976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam).
    Gutmann L; Vincent S; Billot-Klein D; Acar JF; Mrèna E; Williamson R
    Antimicrob Agents Chemother; 1986 Dec; 30(6):906-12. PubMed ID: 3545069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Affinity of penicillin-binding proteins of Escherichia coli K-12 for furbenicillin and other beta-lactam antibiotics].
    Lei Y; Li JT
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):177-80. PubMed ID: 2683579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quaternary heterocyclylamino beta-lactams. II. The in vitro antibacterial properties of L-640,876, a new type of beta-lactam antibiotic.
    Koupal LR; Weissberger B; Shungu DL; Weinberg E; Gadebusch HH
    J Antibiot (Tokyo); 1983 Jan; 36(1):47-53. PubMed ID: 6088458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
    Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ
    J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities.
    Storey C; Chopra I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):303-5. PubMed ID: 11120983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria.
    Brochu A; Brochu N; Nicas TI; Parr TR; Minnick AA; Dolence EK; McKee JA; Miller MJ; Lavoie MC; Malouin F
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2166-75. PubMed ID: 1444296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bactericidal activity of cefotaxime and other beta-lactams by a novel method.
    Satta G; Cornaglia G; Canepari P; Pompei R
    Drugs; 1988; 35 Suppl 2():35-40. PubMed ID: 3293978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria.
    Dalhoff A; Nasu T; Okamoto K
    Chemotherapy; 2003 Jul; 49(4):172-83. PubMed ID: 12886052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-19393 S2 and H2, new carbapenem antibiotics. III. Mode of action.
    Nozaki Y; Kawashima F; Imada A
    J Antibiot (Tokyo); 1981 Feb; 34(2):206-11. PubMed ID: 7028708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin-binding protein inactivation by human neutrophil myeloperoxidase.
    Rakita RM; Rosen H
    J Clin Invest; 1991 Sep; 88(3):750-4. PubMed ID: 1653273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mecillinam resistance in Escherichia coli is conferred by loss of a second activity of the AroK protein.
    Vinella D; Gagny B; Joseleau-Petit D; D'Ari R; Cashel M
    J Bacteriol; 1996 Jul; 178(13):3818-28. PubMed ID: 8682786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murein synthesis and beta-lactam antibiotic susceptibility during rod-to-sphere transition in a pbpA(Ts) mutant of Escherichia coli.
    Botta GA; Buffa D
    Antimicrob Agents Chemother; 1981 May; 19(5):891-900. PubMed ID: 7027927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin-binding proteins in Haemophilus influenzae.
    Makover SD; Wright R; Telep E
    Antimicrob Agents Chemother; 1981 Apr; 19(4):584-8. PubMed ID: 6972731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of beta-lactam antibiotics with penicillin-binding proteins from Bacillus megaterium.
    Rodríguez-Tébar A; Rojo F; Vázquez D
    Eur J Biochem; 1982 Aug; 126(1):161-6. PubMed ID: 6813116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
    Tsuchimori N; Okonogi K
    J Antimicrob Chemother; 1996 Mar; 37(3):605-9. PubMed ID: 9182117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillin-binding proteins of beta-lactam-resistant strains of Staphylococcus aureus. Effect of growth conditions.
    Reynolds PE; Brown DF
    FEBS Lett; 1985 Nov; 192(1):28-32. PubMed ID: 3850810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial properties of SCE-2787, a new cephem antibiotic.
    Nakao M; Noji Y; Iwahi T; Yamazaki T
    J Antimicrob Chemother; 1992 May; 29(5):509-18. PubMed ID: 1624391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.